Delivery Order SPE2DB24D1201-SPE2DB24FJAEM
- Not listed
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,333.31, is for the delivery of REVATIO 20 MG TABLET 90S, a medication used to treat pulmonary arterial hypertension. The delivery order is a firm-fixed-price contract with a completion date of November 7, 2024. This contract is not designated as a set-aside and...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of REVATIO 20 MG TABLET 90S, a pharmaceutical product. The firm-fixed-price contract has a ceiling value of $12,629.20 and an ultimate completion date of August 20, 2024. The contract is not designated as a set-aside. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts and indefinite delivery contracts to provide a wide range of...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of REVATIO 20 mg tablets. The contract has a firm fixed price of $36,949.44 and a completion date of September 26, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and AmerisourceBergen, valued at up to $999,999,999 through December 2025, for the provision of a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,906.65 firm fixed-price delivery order contract is for the supply of REVATIO 20 MG TABLET 90S, a prescription medication used to treat pulmonary arterial hypertension. The contract has an ultimate completion date of December 3, 2024 and is not designated with any set-aside requirements, indicating open...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of REVATIO 20 MG TABLET 90S. The contract has a ceiling value of $37,922.82 and a completion date of September 16, 2024. The contract is a firm-fixed-price type with no set-aside designation. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with various federal agencies, including a DLA Troop Support Medical...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of REVATIO 20 MG TABLET 90S. The contract has a ceiling value of $4,662.96 and an ultimate completion date of September 20, 2024. The award is not associated with a set-aside program. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with DLA and other federal agencies, enabling the efficient procurement of a wide range of...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of REVATIO 20 MG tablets. The contract has a firm fixed price of $8,846.49 and an ultimate completion date of September 13, 2024. AmerisourceBergen is a major pharmaceutical distributor that has been awarded numerous federal contracts to provide a wide range of essential medical commodities, including specialty medications, brand-name and generic drugs, and medical...
- This firm-fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide Revatio 20 mg tablets. The contract has a ceiling value of $2,855.68 and a performance period ending on July 2, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to...
- This federal contract award is for the delivery of the pharmaceutical product REVATIO 20 MG TABLET 90S to the Defense Logistics Agency (DLA). The $14,696.91 firm fixed price contract was awarded to AmerisourceBergen Drug Corp, a major supplier of pharmaceutical and medical products to the U.S. government. The contract has an ultimate completion date of August 15, 2024. This appears to be a one-time delivery order under a larger indefinite delivery contract (IDC) held by AmerisourceBergen with...
- This federal contract award, valued at $22,344.69, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a Delivery Order contract for REVATIO 20 MG TABLET 90S, a medication used to treat pulmonary arterial hypertension. The contract has a firm fixed-price pricing type and an ultimate completion date of January 14, 2025. Amerisourcebergen holds a significant Indefinite Delivery...
- SPE2DB24D1201Indefinite Delivery Contract
- SPE2DB24D1201-SPE2DB24FJAEMDelivery Order
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of REVATIO 20 MG TABLET 90S, a medication used to treat pulmonary arterial hypertension. The contract has a firm fixed price of $19,146.08 and a completion date of June 17, 2024. This contract is not designated as a set-aside. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $19.1k | 6/14/24 |